is compound semaglutide being discontinued Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s What you need to know

Kidney Issues Some research indicates a potential link between GLP-1 agonists and kidney problems, including acute kidney injury

Peptides are short chains of amino acids that act as signaling molecules in the body, regulating essential biological functions such as tissue repair, immune modulation, and hormone balance

While GLP-1 receptor agonists like semaglutide have been widely studied for their effects on appetite and blood sugar, the addition of GIP receptor activation introduces a second metabolic pathway that may influence insulin sensitivity, energy regulation, and even how the body handles dietary fat

Stage 2: Following a two-stage sifting strategy against pre-specified criteria, data on reliability and validity are extracted from each included article